These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6262196)

  • 1. Plasma c-AMP during the normal menstrual cycle and under different hormonal treatment.
    Göser R; Kindler D; Keller E; Schindler AE
    Gynecol Obstet Invest; 1980; 11(6):365-72. PubMed ID: 6262196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J
    Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal contraception and IUDs in adolescents].
    Mall-Haefeli M
    Fortschr Med; 1984 Sep; 102(33):823-4. PubMed ID: 6479825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current developments in hormonal contraception].
    Kuhl H
    Gynakologe; 1992 Aug; 25(4):231-40. PubMed ID: 1398252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstruation: choosing whether...and when.
    Kaunitz AM
    Contraception; 2000 Dec; 62(6):277-84. PubMed ID: 11239613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations].
    Lachnit-Fixson U
    Fortschr Med; 1984 Sep; 102(33):825-30. PubMed ID: 6383993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acceptability of hormonal contraceptives with a low steroid content].
    Dubnitskaia LV
    Akush Ginekol (Mosk); 1988 Aug; (8):47-50. PubMed ID: 3195708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masking effect of hormonal contraceptives on discriminating quantitative features of visually normal intermediate cells in positive and negative cervical smears.
    Kwikkel HJ; Boon ME; van Rijswijk MM; Rietveld WJ; Stolk JG
    Anal Quant Cytol Histol; 1986 Sep; 8(3):227-32. PubMed ID: 3778614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
    Dahiya P; Dalal M; Yadav A; Dahiya K; Jain S; Silan V
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():147-51. PubMed ID: 27285306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral contraceptive (ethinyl estradiol and d-norgestrel) on serum prolactin-oestradiol and progesterone levels.
    Erodogan M; Inal A; Ozgu M; Beksac MS; Ergurbuz I
    Acta Reprod Turc; 1980 Jan; 1(3):85-91. PubMed ID: 12262090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Directions for classification and indications of oral contraceptives (author's transl)].
    d'Ernst JP; Lutz K; Stamm H
    Schweiz Rundsch Med Prax; 1977 Dec; 66(50):1620-7. PubMed ID: 594055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
    Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO
    Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of recurrent menstrual psychosis by an oral contraceptive.
    Felthous AR; Robinson DB; Conroy RW
    Am J Psychiatry; 1980 Feb; 137(2):245-6. PubMed ID: 6101529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.